Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Dihydrostreptomycin sulfate

    ACTIVE PHARMA INGREDIENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder VMF No. Subject Received Date Status Type
    Norbrook Laboratories
    United Kingdom
    		 NORBROOK LABORATORIES LTD 5358 Dihydrostreptomycin sulfate 1991-05-21 Active II
    North China Pharmaceutical Huasheng Co Ltd
    China
    		 NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD 5761 Dihydrostreptomycin sulfate 2002-12-23 Active II